Delivery Order SPE2DB22D3301-SPE2DB24FY8BM
Award Date 6/6/24
Potential Completion Date 6/7/24
Potential Value $1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to deliver Colestipol HCl 1 GM tablets. The contract is a Delivery Order valued at $7,352.07 with a firm fixed price, and has an ultimate completion date of July 24, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $3,809.83, is for the delivery of Colestipol HCl 1 GM Tablet 120S, a pharmaceutical product, and has an ultimate completion date of April 14, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. There is no set-aside designation for this award. Amerisourcebergen Drug Corp holds...
- This federal contract award is a delivery order valued at $1,141.67, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract provides for the delivery of 4,566,373,392 units of Colestipol HCL 1 GM Tablet 120S, a medication used to manage cholesterol levels. The contract has a firm fixed price pricing type and a completion date of November 8, 2024. Amerisourcebergen holds a significant...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, to provide 4,566,053,970 tablets of Colestipol HCl 1 g. The contract is a firm-fixed-price delivery order with a ceiling value of $2,941.44 and a period of performance through October 9, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,106.98, is for the delivery of Colestipol HCL 1 GM Tablets in quantities of 120s. The contract has an ultimate completion date of March 18, 2025 and is a firm fixed-price contract. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
- This federal contract award is a delivery order with a firm fixed price ceiling value of $1,054.44, issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp. The contract is for the supply of Colestipol HCl 1 GM Tablets in 120-count packages, with a period of performance through June 12, 2025. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a significant...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for a Delivery Order contract valued at $1,544.56 for the supply of Colestipol HCL 1 GM Tablets. The award is not associated with a set-aside program and appears to be an open competition contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Colestipol HCL 1 GM Tablets, with a ceiling value of $1,157.80 and a performance period ending on May 20, 2025. The contract is a Firm Fixed Price type and is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This federal contract award is for the delivery of Colestipol HCL 1 GM Tablets in quantities of 120 tablets. The contract was awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has a ceiling value of $9,180.06 and a completion date of October 17, 2023. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating it was awarded through full and open competition....
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $5,462.98 contract is for the delivery of 120 count tablets of Colestipol HCl 1 GM, a medication used to treat high cholesterol. The contract has a completion date of May 9, 2023 and is a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside. Amerisourcebergen holds a larger...